PABPC1L2B-AS1
gene geneOn this page
Summary
PABPC1L2B-AS1 (PABPC1L2B antisense RNA 1, HGNC:50345) is a long non-coding RNA gene on chromosome Xq13.1-q13.2.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:50345 |
| Approved symbol | PABPC1L2B-AS1 |
| Name | PABPC1L2B antisense RNA 1 |
| Location | Xq13.1-q13.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000226725 |
| Ensembl biotype | lncRNA |
| Entrez | 101928345 |
| RNAcentral | URS00000F92BD — lncRNA, 1167 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 22 — 22 lncRNA
ENST00000416989, ENST00000806242, ENST00000806243, ENST00000806244, ENST00000806245, ENST00000806246, ENST00000806247, ENST00000806248, ENST00000806249, ENST00000806250, ENST00000806251, ENST00000806252, ENST00000806253, ENST00000806254, ENST00000806255, ENST00000806256, ENST00000806257, ENST00000806258, ENST00000806259, ENST00000806260, ENST00000806261, ENST00000806262
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000416989 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001628400 | 73002187 | 73002323 |
| ENSE00001686866 | 73001211 | 73001325 |
| ENSE00001772304 | 73002405 | 73002856 |
| ENSE00001788969 | 72998388 | 72998850 |
Expression profiles
Bgee: expression breadth broad, 85 present calls, max score 90.86.
Top tissues by expression
85 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 90.86 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 84.11 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 82.93 | gold quality |
| cerebellum | UBERON:0002037 | 82.77 | gold quality |
| cerebellar cortex | UBERON:0002129 | 82.77 | gold quality |
| bone marrow cell | CL:0002092 | 81.05 | gold quality |
| prostate gland | UBERON:0002367 | 78.80 | gold quality |
| right frontal lobe | UBERON:0002810 | 74.85 | gold quality |
| hypothalamus | UBERON:0001898 | 73.64 | gold quality |
| amygdala | UBERON:0001876 | 73.51 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 73.39 | gold quality |
| temporal lobe | UBERON:0001871 | 73.11 | gold quality |
| brain | UBERON:0000955 | 73.09 | gold quality |
| substantia nigra | UBERON:0002038 | 72.47 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 72.01 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 71.98 | gold quality |
| Ammon’s horn | UBERON:0001954 | 71.59 | gold quality |
| cerebral cortex | UBERON:0000956 | 71.58 | gold quality |
| putamen | UBERON:0001874 | 71.53 | gold quality |
| nucleus accumbens | UBERON:0001882 | 71.52 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 71.40 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 71.25 | gold quality |
| minor salivary gland | UBERON:0001830 | 71.23 | gold quality |
| frontal cortex | UBERON:0001870 | 70.59 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 70.52 | gold quality |
| caudate nucleus | UBERON:0001873 | 70.38 | gold quality |
| pituitary gland | UBERON:0000007 | 68.58 | gold quality |
| primary visual cortex | UBERON:0002436 | 67.87 | gold quality |
| liver | UBERON:0002107 | 65.15 | silver quality |
| adenohypophysis | UBERON:0002196 | 64.99 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.16 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.